268 related articles for article (PubMed ID: 19329438)
1. The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation.
Roda-Navarro P; Reyburn HT
J Biol Chem; 2009 Jun; 284(24):16463-16472. PubMed ID: 19329438
[TBL] [Abstract][Full Text] [Related]
2. Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1.
Park YP; Choi SC; Kiesler P; Gil-Krzewska A; Borrego F; Weck J; Krzewski K; Coligan JE
Blood; 2011 Sep; 118(11):3019-27. PubMed ID: 21816829
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S
BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211
[TBL] [Abstract][Full Text] [Related]
4. Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function.
Roda-Navarro P; Vales-Gomez M; Chisholm SE; Reyburn HT
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11258-63. PubMed ID: 16849432
[TBL] [Abstract][Full Text] [Related]
5. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.
Sun C; Fu B; Gao Y; Liao X; Sun R; Tian Z; Wei H
PLoS Pathog; 2012; 8(3):e1002594. PubMed ID: 22438812
[TBL] [Abstract][Full Text] [Related]
7. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells.
Quatrini L; Molfetta R; Zitti B; Peruzzi G; Fionda C; Capuano C; Galandrini R; Cippitelli M; Santoni A; Paolini R
Sci Signal; 2015 Oct; 8(400):ra108. PubMed ID: 26508790
[TBL] [Abstract][Full Text] [Related]
9. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.
Wu J; Chalupny NJ; Manley TJ; Riddell SR; Cosman D; Spies T
J Immunol; 2003 Apr; 170(8):4196-200. PubMed ID: 12682252
[TBL] [Abstract][Full Text] [Related]
10. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
[TBL] [Abstract][Full Text] [Related]
11. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
Front Immunol; 2018; 9():1282. PubMed ID: 29963042
[TBL] [Abstract][Full Text] [Related]
12. The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure.
Garrity D; Call ME; Feng J; Wucherpfennig KW
Proc Natl Acad Sci U S A; 2005 May; 102(21):7641-6. PubMed ID: 15894612
[TBL] [Abstract][Full Text] [Related]
13. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H; Kim J; Cosman D; Choi I
Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
[TBL] [Abstract][Full Text] [Related]
14. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
15. Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12.
Fikri Y; Nyabenda J; Content J; Huygen K
Immunogenetics; 2007 Aug; 59(8):653-9. PubMed ID: 17530242
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors.
Hu L; Cao D; Li Y; He Y; Guo K
Cancer Biol Ther; 2012 May; 13(7):516-26. PubMed ID: 22406996
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of activating NK-cell receptors 2B4 and NKG2D to membrane microdomains in mammalian cells is dependent on their transmembrane regions.
Gütgemann SA; Sandusky MM; Wingert S; Claus M; Watzl C
Eur J Immunol; 2015 Apr; 45(4):1258-69. PubMed ID: 25545687
[TBL] [Abstract][Full Text] [Related]
18. Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand.
Nakamura K; Nakayama M; Kawano M; Amagai R; Ishii T; Harigae H; Ogasawara K
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9421-6. PubMed ID: 23690625
[TBL] [Abstract][Full Text] [Related]
19. A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells.
Chang YH; Connolly J; Shimasaki N; Mimura K; Kono K; Campana D
Cancer Res; 2013 Mar; 73(6):1777-86. PubMed ID: 23302231
[TBL] [Abstract][Full Text] [Related]
20. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions.
Sutherland CL; Chalupny NJ; Cosman D
Immunol Rev; 2001 Jun; 181():185-92. PubMed ID: 11513139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
